Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Jbtm Stock Analysis Jbt Marel Corporation 2.81 Dip At 125.15 Performance Review 20260403 Bdc Stock Analysis Belden Inc Drops 1.34 Percent To 115.05 Key Support Levels To Watch 20260403 1 Is Aeye Inc. Lidrw Stock A Safe Investment Price At 0.03 Down 1.64 20260406 Is John Wiley Wlyb Stock A Buy Now Wlyb Q1 2026 Earnings John Wiley And Sons Inc Notches 12 Eps Beat 20260406 Is Momentum Building In Compass Div Codi Stock Price At 9.61 Up 0.63 20260408 Coffee JVA shares climb 4 as 226 revenue growth offsets earnings miss surprising investors LI Li Auto EPS smashes estimates at 108 vs 00255 but revenue slides 222 YoY United PRKS Stock Why Cost Reduction Technical Strength 20260418 FET Forum Energy Technologies Inc reports Q4 2025 EPS beat but shares drop 681 amid lack of disclosed revenue details FRMI Fermi shares climb 38 despite 977 EPS miss investors upbeat on outlook Yorkville MCGA Stock Retest Trade Unchanged 20260420 QuinStreet QNST Stock Market Opportunities Near Highs 20260420 What is the outlook for Orla ORLA stock today Orla posts 95 pct EPS beat vs analyst forecasts ADSK Autodesk Q1 2026 earnings top estimates as 175 yearoveryear revenue growth lifts shares modestly Valero Energy Corporation VLO Bullish PreEarnings Outlook Signals Strong Q1 2026 Beat Potential The recurring revenue story behind Nuveen Dow30 DIAX DIAX Latest Quarter Earnings Nuveen Dow30 has no consensus earnings tied to Dow30 overwrite results Where could Evercore EVR stock be by the end of 2026 Q4 2025 EPS Exceeds Expectations NMAI Nuveen details multiasset income market positioning and capital allocation plans in its latest quarterly earnings report RNP Cohen and management highlights stable portfolio performance in latest quarterly earnings update Rupee Weakens Further Opens at 9637 Against US Dollar Amid Persistent Crude Price Pressure HR Block HRB Q1 2026 Earnings 602 EPS Surges Past 583 Estimates Precious Metals Decline Intensifies Market Weighs Potential Entry Points US Treasury Secretary Bessent Cites Leadership in AI as Rationale for Talks with China on Safety Protocol Ethan ETD Flat at 1894 Consolidation Continues 20260515 Amphastar AMPH Fell 257 Is a Recovery Ahead 20260514 Modular Medical MODD Q3 2025 Earnings Miss by Significant Key Takeaways Socket Mobile SCKT Declines 114 Amid Market Weakness 20260518 Ultralife Corporation ULBI Surges 484 as Momentum Builds DR Horton DHI Q1 2026 Earnings Why the Beat Matters Trump Postpones AI Executive Order Amid White House Infighting and China Competition Fears Hancock HWCPZ Blows Past Q1 2026 Forecasts EPS Hits 152 Big Techs Influence on Trumps AI Executive Order Reversal Why Avoiding AI Tools May Preserve Human Cognition in an Era of TechDriven Efficiency Gold Correction May Be Approaching Its End as Sentiment Indicators Shift ixigo Partners with Uber and redBus to Enhance Train Travel Experience Jardine Matheson to Acquire IMED Radiology Network in 24 Billion Deal Newegg Commerce Inc NEGG Q4 2022 Earnings Significant EPS Miss Reflects Challenging Quarter CRDO Q1 2026 Earnings Strong EPS Beat Drives DoubleDigit Stock Surge Fortive Q1 2026 Earnings Strong EPS Beat Bolsters Investor Confidence NanoViricides Inc NNVC Q1 2026 Earnings Narrower Loss Drives Positive Stock Reaction Voyager Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction Petco WOOF Jumps Over 4 as Shares Test Key Resistance at 290 Presurance Holdings Notes PRHIZ Steady at 1744 as Market Weighs Credit and Rate Risks NMI Holdings NMIH Holds Steady Near 37 as Trading Volumes Suggest Bearish Caution ePlus Inc PLUS Edges Higher as Stock Holds Above Key Support Levels RLJ RLJ Q1 2026 Earnings Outperformance Signals Momentum Gainers Losers BEL Zee Lead Midweek Movers as Deccan Gold Mines and GE Vernova Surge Alphabets Google IO Showcase A Crucial Moment to Reinforce AI Leadership to Wall Street Bicara Therapeutics BCAX Shows Modest Gains as Biotech Sector Eyes Key Resistance Levels Janux Therapeutics JANX Rallies 377 as Bulls Target 1505 20260520